Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Belgium

Research and Innovation Action · Running

NOMAD Novel biomaterials to prevent dental peri-implant infections

Coordinator
Katholieke Universiteit Leuven, Belgium
Runs
1 December 2022 to 31 May 2027
Status
Running
EU funding
€4.7m
Total cost
€4.7m
Partners
12 organisations in 7 countries
Type
Research and Innovation Action
Grant agreement
101091669

What the project is doing

In the project's own words, from its summary on CORDIS.

Peri-implant infections are a devastating complication of dental implants, occurring in approximately 20% of all patients, that can ultimately lead to implant instability and loss. Considering this high prevalence rate and the lack of predictive treatments in severe cases, prevention of peri-implantitis has become a major challenge in clinical dentistry. NOMAD will develop innovative biomaterial approaches for dental implants, from TRL3 to TRL5.

Various functionalised implant coatings for titanium and zirconia implant surfaces will reduce the risk of infection (and associated inflammation), improve soft-tissue sealing at the gum line, and promote osseointegration. A further innovation are multi-material crowns and abutments using additive manufacturing combined with grafting of nanotubes, enabling controlled release of prebiotic as well as antimicrobial compounds in response to bacterial adhesion at the onset of infection (i.e. smart conditional release).

A combination of these approaches will be employed in the final product to provide a customisable, all-round solution focusing on crown, abutment and/or fixture for prevention of peri-implantitis. Advanced in vitro testing using complex cell co-cultures in bioreactor systems, and biomechanical stability tests will enable selecting the most promising biomaterials for testing in relevant in vivo models. These results will enable rapid progression to first-in-human studies of new biomaterials after the project.

A cost-benefit and regulatory analysis will be performed and an innovation management strategy will develop a roadmap for commercialisation. The NOMAD consortium includes a major dental implant manufacturer, academic groups, SMEs working on biomaterials innovation and a specialist innovation company. The project is a major opportunity for enhancing EU competitiveness in biomaterials and inter-sector technology transfer.

Topics

Who is involved

OrganisationCityCountryRole
Katholieke Universiteit LeuvenLeuvenBelgiumCoordinator
Health HouseHeverleeBelgiumThird party
Atrineo AGKarlsruheGermanyParticipant
Universitaet SiegenSiegenGermanyParticipant
Universidad Complutense De MadridMadridSpainParticipant
Anthogyr SASSallanchesFranceParticipant
Centre National De La Recherche Scientifique CNRSParisFranceParticipant
Ecole Centrale De LyonEcullyFranceThird party
Croom Precision Tooling LimitedLimerickIrelandParticipant
Glantreo LimitedCorkIrelandParticipant
Academisch Ziekenhuis GroningenGroningenNetherlandsParticipant
Educell Podjetje Za Celicno Biologi Jo DooTrzinSloveniaParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI